<DOC>
	<DOCNO>NCT01329965</DOCNO>
	<brief_summary>The purpose study establish safety feasibility low dose LPS administration small subset human preparation large USDA fund study examine low effective dose EPA + DHA ( 300 , 600 , 900 1,800 mg/day deliver fish oil supplement ) significantly attenuate inflammatory response investigator wish examine effect endotoxemia model induce inflammation . Based previous research , low dose LPS administration affect metabolism human minimal clinical effect ( `` flu '' like illness ) . Therefore , six subject include small pilot study receive low dose LPS placebo order learn metabolic change occur administration inflammation . The investigator hypothesis LPS administration elicit minimal clinical effect ( `` flu '' like illness ) compare placebo ( saline -- water amount salt blood ) .</brief_summary>
	<brief_title>Safety Feasibility Endotoxemia Model</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Endotoxemia</mesh_term>
	<criteria>Healthy men nonpregnant/lactating woman age 20 35 year old BMI &gt; 19.9 &lt; 30.0 Able give write informed consent willing comply study related procedure Previous history heart disease diabetes Renal Insufficiency Chronic antiinflammatory use Systolic blood pressure &lt; 90 Individuals currently use tobacco product do previous 30 day Individuals take Omega3 fatty acid supplement usual intake fish great 34 serving per month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Inflammation</keyword>
	<keyword>LPS</keyword>
	<keyword>Endotoxin</keyword>
</DOC>